NCT04964817View on ClinicalTrials.gov

HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

August 3, 2021

Primary Completion Date

April 12, 2023

Study Completion Date

April 12, 2023

Conditions
Heart Failure With Preserved Ejection FractionVenous Disease
Trial Locations (1)

62769

Prairie Heart Institute at St. Johns Hospital, Springfield

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

collaborator

Medtronic

INDUSTRY

collaborator

Philips Healthcare

INDUSTRY

lead

Prairie Education and Research Cooperative

INDUSTRY

NCT04964817 - HFpEF and Symptomatic Obstructive Iliofemoral Venous Disease Study | Biotech Hunter | Biotech Hunter